Growing out of the old self: management itself says the company has quietly become a different business, and the numbers
The model's full reasoning — Q2 2018 call → NOWe need answer YES or NO based on transcript. Need determine if management conveys company today running on different basis than reported results/reputation built on, with both halves: change of basis already real, and record/perception lag change. Let's parse transcript. Fresenius Medical Care Q2 2018. Key topics: Care Coordination margin improvement, Calcimimetics transition from Part D to Part B, pharmacy to clinics, divestment of Sound, ESRD PPS draft rule, etc. Need see if management describes company as now operating on genuinely different foundation vs past, and that reported results/outside perception lag. Look for statements. Rice: "We're on track to achieve 2018 targets. Q2 good quarter improvement from Q1... continue progress." Highlights: results impacted by currency headwinds. Solid organic growth. Care Coordination margin improvement and revenue decline came in as expected. Calcimimetics continue to evolve. Moving from Part D in David to Part B in Barry. Pharmacy to clinics. Two quarters in to two to four quarter process. Divestment of Sound. ESRD PPS draft rule. Mike: revenue growth comparable basis, IFRS 15 adjustments, VA settlement. Net income growth. Margins. Care Coordination margins. Sound divestiture gain. Guidance. Question asks: Does management convey that THE COMPANY TODAY IS RUNNING ON A DIFFERENT BASIS THAN THE COMPANY ITS REPORTED RESULTS AND REPUTATION WERE BUILT ON — that is, does management itself describe the company as having crossed, recently and substantially, into being a different kind of business than it was, while making clear that this change is not yet what the reported numbers or the outside picture of the company reflect? Need identify if management says company now operates differently at root. Possible candidates: Calcimimetics transition from Part D to Part B, pharmacy to clinics. This is a change in how drugs are reimbursed and administered. But is that a "different kind of business"? It's a shift in revenue/cost per treatment, not fundamental business model. Also Care Coordination? Sound divestment? Not necessarily. Maybe management describes "Care Coordination" as a new business? But they've had it. They mention "we're moving from Part D in David to Part B in Barry. Pharmacy to the clinics." This is a change in how calcimimetics are provided. But management says it's a medical decision, titration.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SANG | Sangoma Technologies Corporation | Q2 2024 | 2024-02-08 | D |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| CAG | Conagra Brands, Inc. | Q2 2017 | 2016-12-22 | C+ |
CALX · Q1 2023 → YESThe question is whether management conveys that the company today is running on a different basis than what its reported results and reputation were built on. Both parts: a change of basis already rea...YES The transcript shows management describing the company as now operating on a fundamentally different basis—selling into a new market of broadband service providers building consolidated networks, shifting from a legacy cyclical model to sequential revenue through platforms, clouds, and managed services—while treating this as an accomplished reality today, not a future plan. They emphasize numbers like 988 BSP deployments, 865 cloud customers, and 334 managed services customers, along with three years of over 25% growth, as evidence of this new foundation already in place.
SANG · Q2 2024 → YESThe question is whether management conveys that the company today is running on a different basis than the one its reported results and reputation were built on. Both parts: a real change of basis alr...
WD · Q2 2022 → YESThe question is whether management conveys that the company today is running on a different basis than the company its reported results and reputation were built on. Specifically, two parts: a change ...